1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. NEWAMSTERDAM PHARMA COMPANY NV
NewAmsterdam Pharma Company NV XNAS: NAMS
35.46 1.18 (3.44%)
697.8K
XNAS Volume

XNAS 27 Feb, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert

Insider Trade
Michael Davidson, CEO and Director of NewAmsterdam Pharma, sells 300K shares worth $10.6 million See details